Cero Therapeutics insider reports 8.67% stake

CERO THERAPEUTICS HOLDINGS, INC. reports that Isaiah Tibbs beneficially owns 1,830,007 shares of Common Stock, representing 8.67% of the class.

Rhea-AI Filing Summary

CERO THERAPEUTICS HOLDINGS, INC. reports that Isaiah Tibbs beneficially owns 1,830,007 shares of Common Stock, representing 8.67% of the class. The filing states Tibbs has sole power to vote and sole dispositive power over all 1,830,007 shares.

Insights

Corporate Governance Analyst

Beneficial owner now holds a significant minority stake with sole voting control.

The filing identifies 1,830,007 shares and 8.67% ownership with sole voting and dispositive power. This level creates a visible holder with unilateral voting control over those shares, which could matter for proxy dynamics.

Stake implications depend on future disclosures of related agreements or additional filings; subsequent filings would clarify intent or coordination with other holders.

Securities Compliance Expert

Schedule 13G disclosure documents passive beneficial ownership above the 5% threshold.

The report lists the holder, address, class (Common Stock), and CUSIP 15687V102. The filing format signals disclosure of beneficial ownership consistent with Section 13 rules rather than an active solicitation.

Regulatory follow-up would occur if ownership crosses other thresholds or the holder changes status; no such changes are disclosed here.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Schedule 13G filed for CERO reveal about Isaiah Tibbs' holdings?

It discloses 1,830,007 shares of Common Stock, representing 8.67% of the class. The filing records sole voting and sole dispositive power over those shares and cites CUSIP 15687V102.

Does the filing show whether Tibbs shares voting power with others for CERO?

No; the Schedule 13G states Tibbs has sole voting power of 1,830,007 shares and shared voting power of 0. The filing therefore reports unilateral voting control over the disclosed position.

Is the Tibbs position in CERO a majority or minority stake?

It is a minority stake. The filing reports Tibbs beneficially owns 1,830,007 shares, which the document lists as 8.67% of the outstanding class of Common Stock.

What class and CUSIP are associated with the disclosed CERO shares?

The filing lists the security as Common Stock and provides CUSIP 15687V102. These identifiers are included alongside the beneficial ownership and voting power disclosures.

Who signed the ownership disclosure for CERO and how is control described?

The signature block lists the reporting person as Isaiah Tibbs signing the form. The disclosure states Tibbs has sole power to vote and sole power to dispose of the 1,830,007 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/12/2026 - 03:38 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

CERO THERAPEUTICS HOLDINGS, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

02/19/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP Number(s):

1

Names of Reporting Persons

Tibbs Isaiah

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,830,007.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,830,007.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,830,007.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.67 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CERO THERAPEUTICS HOLDINGS, INC.
(b)	Address of issuer's principal executive offices: 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CALIFORNIA 94080
Item 2.
(a)	Name of person filing: Tibbs Isaiah
(b)	Address or principal business office or, if none, residence: 706 Park Blvd. Austin, TX 78751
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 15687V102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,830,007
(b)	Percent of class: 8.67 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,830,007
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1,830,007
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Tibbs Isaiah

Signature:	Tibbs Isaiah
Name/Title:	Individual
Date:	03/12/2026